Edwards Lifesciences to Present at Citi's 2026 Unplugged Medtech Event

The leading global structural heart innovation company will showcase its latest advancements at the annual industry conference.

Published on Feb. 13, 2026

Edwards Lifesciences Corporation, a leading global structural heart innovation company, announced that it will participate in Citi's Unplugged Medtech and Life Sciences Access Day on February 26, 2026. Scott Ullem, the company's chief financial officer, is scheduled to present at 10:15 a.m. ET, with a live webcast available on the Edwards Lifesciences investor relations website.

Why it matters

As a pioneer in structural heart innovations, Edwards Lifesciences' participation in this high-profile industry event highlights the company's commitment to advancing medical technologies that can improve patient lives. The presentation will provide investors and stakeholders an opportunity to learn about the company's latest developments and strategic priorities.

The details

Edwards Lifesciences is known for its breakthrough technologies, world-class evidence, and partnerships with clinicians and healthcare stakeholders. The company's patient-focused culture drives its employees to deliver life-changing innovations to those who need them most.

  • Edwards Lifesciences will present at Citi's Unplugged Medtech and Life Sciences Access Day on February 26, 2026.
  • The live webcast of the presentation will be available on the Edwards Lifesciences investor relations website on the same day.

The players

Edwards Lifesciences Corporation

A leading global structural heart innovation company, driven by a passion to improve patient lives through breakthrough technologies, world-class evidence, and partnerships with clinicians and healthcare stakeholders.

Scott Ullem

The chief financial officer of Edwards Lifesciences Corporation, who is scheduled to present at the Citi event.

Got photos? Submit your photos here. ›

The takeaway

Edwards Lifesciences' participation in the Citi Unplugged Medtech and Life Sciences Access Day underscores the company's commitment to advancing medical technologies and showcasing its latest innovations to investors, industry stakeholders, and the broader healthcare community.